Trial NCT01018563

View at ClinicalTrials.gov 
Org. Study IDs: MORAb-003-002A
Secondary IDs: 2009-015825-36

Last trial update was posted on 2021-12-08

MeSH Interventions

Farletuzumab

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Epithelial Ovarian Cancer

Stopping Reasons

Study was terminated by sponsor due to futile results in NCT00849667 study.

Limitations And Caveats

Study was terminated by sponsor due to futile results in the NCT00849667 (MORAb003-004) study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID